Your browser doesn't support javascript.
loading
How to treat splenic marginal zone lymphoma (SMZL) in patients unfit for surgery or more aggressive therapies: experience in 30 cases.
Cervetti, Giulia; Ghio, Francesco; Cecconi, Nadia; Morganti, Riccardo; Galimberti, Sara; Petrini, Mario.
Afiliação
  • Cervetti G; a Department of Oncology, Transplants and Advances in Medicine , Section of Hematology, University of Pisa , Pisa , Italy.
  • Ghio F; a Department of Oncology, Transplants and Advances in Medicine , Section of Hematology, University of Pisa , Pisa , Italy.
  • Cecconi N; a Department of Oncology, Transplants and Advances in Medicine , Section of Hematology, University of Pisa , Pisa , Italy.
  • Morganti R; b Department of Oncology, Biostatistical Consulting , University Hospital S. Chiara , Pisa , Italy.
  • Galimberti S; a Department of Oncology, Transplants and Advances in Medicine , Section of Hematology, University of Pisa , Pisa , Italy.
  • Petrini M; a Department of Oncology, Transplants and Advances in Medicine , Section of Hematology, University of Pisa , Pisa , Italy.
J Chemother ; 29(2): 126-129, 2017 Apr.
Article em En | MEDLINE | ID: mdl-27454143

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esplênicas / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Zona Marginal Tipo Células B Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esplênicas / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Zona Marginal Tipo Células B Idioma: En Ano de publicação: 2017 Tipo de documento: Article